Trial
NCT04858451
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Thirty Respiratory Limited
Collaborators
—
Condition
COPD
Intervention
RESP301
Why stopped
Study stopping criteria were met. A safety event has occurred which was classified as an SAE and was related to the study intervention.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-31